Deutsche Bank
BLRX

Deutsche Bank’s BioLineRX BLRX Stock Holding History

Deutsche Bank’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-102
Closed -$26K – 5180
2018
Q4 		$26K Buy
+102
New +$49.1K ﹤0.01% 4675
2018
Q2 		– Sell
-151
Closed -$78K – 5414
2018
Q1 		$78K Sell
151
-304
-67% -$186K ﹤0.01% 4599
2017
Q4 		$297K Sell
455
-2,573
-85% -$1.7M ﹤0.01% 3839
2017
Q3 		$2.03M Buy
3,028
+2,143
+242% +$1.33M ﹤0.01% 2526
2017
Q2 		$448K Buy
885
+290
+49% +$149K ﹤0.01% 3510
2017
Q1 		$342K Buy
595
+239
+67% +$154K ﹤0.01% 3298
2016
Q4 		$196K Hold
356
– – ﹤0.01% 3690
2016
Q3 		$245K Sell
356
-50
-12% -$26.6K ﹤0.01% 3552
2016
Q2 		$194K Hold
406
– – ﹤0.01% 3790
2016
Q1 		$248K Hold
406
– – ﹤0.01% 3555
2015
Q4 		$316K Sell
406
-468
-54% -$388K ﹤0.01% 3486
2015
Q3 		$802K Sell
874
-203
-19% -$217K ﹤0.01% 3087
2015
Q2 		$1.72M Hold
1,077
– – ﹤0.01% 2584
2015
Q1 		$1.36M Buy
1,077
+539
+100% +$663K ﹤0.01% 2694
2014
Q4 		$522K Buy
538
+218
+68% +$189K ﹤0.01% 3637
2014
Q3 		$295K Hold
320
– – ﹤0.01% 3842
2014
Q2 		$399K Sell
320
-52
-14% -$65.1K ﹤0.01% 3637
2014
Q1 		$497K Buy
372
+132
+55% +$217K ﹤0.01% 3338
2013
Q4 		$405K Sell
240
-101
-30% -$163K ﹤0.01% 3250
2013
Q3 		$446K Buy
341
+134
+65% +$158K ﹤0.01% 3588
2013
Q2 		$200K Buy
+207
New +$214K ﹤0.01% 3820

Other funds holding BLRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank's BLRX Position: Q1 2019 in Review

Deutsche Bank sold out of BioLineRX (BLRX) in Q1 2019, closing a stake of 102 shares — an estimated $26K sold.

Deutsche Bank first reported a position in BLRX in Q2 2013 and held it in 21 quarters. The position peaked at $2.03M in Q3 2017. 31 funds tracked by Wall St. Rank hold BLRX as of Q1 2019.

  • Deutsche Bank reported no remaining BioLineRX position as of Q1 2019 after selling out during the quarter.
  • Deutsche Bank sold 102 BioLineRX shares in Q1 2019, an estimated $26K.
  • Deutsche Bank first reported a position in BioLineRX in Q2 2013 and held it in 21 quarters.
  • Deutsche Bank's BioLineRX position peaked at $2.03M in Q3 2017.
  • 31 funds tracked by Wall St. Rank held BioLineRX as of Q1 2019.

Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.